Literature DB >> 22651864

Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake.

Jan Bucerius1, Venkatesh Mani, Colin Moncrieff, James H F Rudd, Josef Machac, Valentin Fuster, Michael E Farkouh, Zahi A Fayad.   

Abstract

OBJECTIVES: In this study, the impact of noninsulin-dependent type 2 diabetes mellitus on carotid wall (18)F-fluorodeoxyglucose (FDG) uptake in patients with documented or suspected cardiovascular disease was evaluated.
BACKGROUND: Inflammation is a pivotal process in the progression of atherosclerosis, which can be noninvasively imaged by FDG positron emission tomography (FDG-PET).
METHODS: Carotid artery wall FDG uptake was quantified in 134 patients (age 60.2 ± 9.7 years; diabetic subjects, n = 43). The pre-scan glucose (gluc) level corrected mean of the maximum standardized uptake value (SUV) values ((mean)SUV(gluc)), mean of the maximum target-to-background ratio ((mean)TBR(gluc)), and single hottest segment (SHS(gluc)) of FDG uptake in the artery wall were calculated. Associations between FDG uptake, the presence of risk factors for atherosclerosis, and diabetes were then assessed by multiple regression analysis with backward elimination.
RESULTS: The study demonstrated a significant association between diabetes and FDG uptake in the arterial wall (diabetes (mean)SUV(gluc) β = 0.324, (mean)TBR(gluc) β = 0.317, and SHS(gluc) β = 0.298; for all, p < 0.0001). In addition, in diabetic patients, both body mass index ≥ 30 kg/m(2) ((mean)SUV(gluc) β = 0.4, (mean)TBR(gluc) β = 0.357, and SHS(gluc) β = 0.388; for all, p < 0.015) and smoking ((mean)TBR(gluc), β = 0.312; SHS(gluc), β = 0.324; for all, p < 0.04) were significantly associated with FDG uptake.
CONCLUSIONS: Type 2 diabetes was significantly associated with carotid wall FDG uptake in patients with known or suspected cardiovascular disease. In diabetic patients, obesity and smoking add to the risk of increased FDG uptake values.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22651864      PMCID: PMC3392202          DOI: 10.1016/j.jacc.2011.11.069

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  27 in total

1.  Vascular imaging with 18F-FDG PET/CT: optimal 18F-FDG circulation time?

Authors:  James H F Rudd; Maysoon Elkhawad; Zahi A Fayad
Journal:  J Nucl Med       Date:  2009-08-18       Impact factor: 10.057

2.  Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography.

Authors:  Ahmed Tawakol; Raymond Q Migrino; Udo Hoffmann; Suhny Abbara; Stuart Houser; Henry Gewirtz; James E Muller; Thomas J Brady; Alan J Fischman
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

Review 3.  New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.

Authors:  Antonio Ceriello
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

4.  Vascular inflammation imaging with 18F-FDG PET/CT: when to image?

Authors:  Leon J Menezes; Carl W Kotze; Brian F Hutton; Raymondo Endozo; John C Dickson; Ian Cullum; Syed W Yusuf; Peter J Ell; Ashley M Groves
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

5.  Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro.

Authors:  Jan Thiess Deichen; Olaf Prante; Michaela Gack; Kristin Schmiedehausen; Torsten Kuwert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-11-05       Impact factor: 9.236

6.  Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Cathy Anne Pinto; Christopher Tong; Ash Rafique; Richard Hargeaves; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Nucl Med       Date:  2008-05-15       Impact factor: 10.057

7.  Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Tae Nyun Kim; Sungeun Kim; Sae Jeong Yang; Hye Jin Yoo; Ji A Seo; Sin Gon Kim; Nan Hee Kim; Sei Hyun Baik; Dong Seop Choi; Kyung Mook Choi
Journal:  Circ Cardiovasc Imaging       Date:  2010-01-08       Impact factor: 7.792

8.  The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas.

Authors:  K J Langen; U Braun; E Rota Kops; H Herzog; T Kuwert; B Nebeling; L E Feinendegen
Journal:  J Nucl Med       Date:  1993-03       Impact factor: 10.057

9.  Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Mark Woodward; Valentin Fuster; Michael E Farkouh; Zahi A Fayad
Journal:  Circ Cardiovasc Imaging       Date:  2009-01-26       Impact factor: 7.792

10.  Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome.

Authors:  Nobuhiro Tahara; Hisashi Kai; Sho-ichi Yamagishi; Minori Mizoguchi; Hiroyuki Nakaura; Masatoshi Ishibashi; Hayato Kaida; Kenkichi Baba; Naofumi Hayabuchi; Tsutomu Imaizumi
Journal:  J Am Coll Cardiol       Date:  2007-03-26       Impact factor: 24.094

View more
  24 in total

1.  Quantifying [¹⁸F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction.

Authors:  Björn A Blomberg; Arjun Bashyam; Abhinay Ramachandran; Saeid Gholami; Sina Houshmand; Ali Salavati; Tom Werner; Habib Zaidi; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-05-12       Impact factor: 9.236

2.  Dual energy computed tomography quantification of carotid plaques calcification: comparison between monochromatic and polychromatic energies with pathology correlation.

Authors:  Lorenzo Mannelli; Lawrence MacDonald; Marcello Mancini; Marina Ferguson; William P Shuman; Monica Ragucci; Serena Monti; Dongxiang Xu; Chun Yuan; Lee M Mitsumori
Journal:  Eur Radiol       Date:  2014-12-24       Impact factor: 5.315

3.  Delayed ¹⁸F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA study.

Authors:  Björn A Blomberg; Anders Thomassen; Richard A P Takx; Malene G Hildebrandt; Jane A Simonsen; Karen M Buch-Olsen; Axel C P Diederichsen; Hans Mickley; Abass Alavi; Poul F Høilund-Carlsen
Journal:  J Nucl Cardiol       Date:  2014-03-15       Impact factor: 5.952

Review 4.  Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification.

Authors:  Saeid Gholami; Ali Salavati; Sina Houshmand; Thomas J Werner; Abass Alavi
Journal:  J Nucl Cardiol       Date:  2015-04-01       Impact factor: 5.952

Review 5.  The advancing clinical impact of molecular imaging in CVD.

Authors:  Eric A Osborn; Farouc A Jaffer
Journal:  JACC Cardiovasc Imaging       Date:  2013-12

Review 6.  (18)F-FDG PET and vascular inflammation: time to refine the paradigm?

Authors:  Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2015-04       Impact factor: 5.952

Review 7.  Evolving Role of Molecular Imaging with (18)F-Sodium Fluoride PET as a Biomarker for Calcium Metabolism.

Authors:  William Raynor; Sina Houshmand; Saeid Gholami; Sahra Emamzadehfard; Chamith S Rajapakse; Björn Alexander Blomberg; Thomas J Werner; Poul F Høilund-Carlsen; Joshua F Baker; Abass Alavi
Journal:  Curr Osteoporos Rep       Date:  2016-08       Impact factor: 5.096

Review 8.  PET-Based Imaging of Ischemic Heart Disease.

Authors:  Kevin Chen; Edward J Miller; Mehran M Sadeghi
Journal:  PET Clin       Date:  2019-02-01

9.  Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis.

Authors:  Zahi A Fayad; Jeffrey D Greenberg; Jan Bucerius
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

10.  Carotid Artery FDG Uptake May Serve as a Biomarker for Cardiovascular Risk Stratification in Asymptomatic Adults.

Authors:  Dong Hyun Lee; Su Jin Lee; Duck-Joo Lee; Soo Hyun Kwon; Kyung-Sook Jo; Young-Sil An; Joon-Kee Yoon
Journal:  Nucl Med Mol Imaging       Date:  2014-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.